Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses
Research and development (including $13 and $46 for a related party)	$ 6,030	$ 1,961
General and administrative (including $151 and $49 for a related party)	4,324	602
Total operating expenses	10,354	2,563
Loss from operations	(10,354)	(2,563)
Change in fair value of tranche liability (including $331 and $0 for a related party)	365	0
Change in fair value of derivative liabilities (including $1,165 and $0 for a related party)	1,229	0
Interest expense (including $1,384 and $78 for a related party)	(1,443)	(78)
Loss on issuance of convertible promissory notes (including $169 and $793 for a related party)	(186)	(793)
Other income (expense), net	193	27
Total other income (expense), net	158	(844)
Net loss and comprehensive loss	$ (10,196)	$ (3,407)
Net loss per share attributable to common stockholders - basic	$ (2.52)	$ (2.60)
Net loss per share attributable to common stockholders - diluted	$ (2.52)	$ (2.60)
Weighted-average shares outstanding - basic	4,053,140	1,312,552
Weighted-average shares outstanding - diluted	4,053,140	1,312,552